Newsletter – 02

COMING SOON Lidocaine HCl, USP, 1%, 5 mL Ampules We are in the final stages of obtaining FDA approval of an Abbreviated New Drug Application (ANDA), and we expect to have product for sale by late Q1 of 2018. [...]

read more

Newsletter – 01

2017: A YEAR OF INNOVATION If you asked founder Anthony C. Arrigo, “What’s new at Spectra”, the answer would have to be “everything”.  2017 has been a year of tremendous growth and innovation driven by multiple factors.  The addition [...]

read more
Showing 3–4 of 4 results